Welcome to Prospect - a support group for prostate cancer patients, their wives, partners and carers.
Prospect is run by prostate cancer survivors for the benefit of the communities in Bristol and surrounding districts

  • Speakers booked for two meetings

    Our  next members’ meeting is on January 18 and the speaker will be Helen Shallcross from Macmillan. She will talk about the Macmillan 121 service and how it can help men and carers locally. There will also be an informal get-together on Friday, March 4. And on April 21 Dr Amit Bahl will  give an overview of available modalities for treatment. But please note that in future meetings will begin at 7pm. The meetings are at BAWA, Filton.

  • Tree of Hope date fixed

    The Macmillan Tree of Hope celebration at the NGS Macmillan Wellbeing Centre at Southmead is on December 7 (6.30-8pm). There will be mince pies and carols and people will be able to add the name of a loved one living with or beyond cancer to a star and hang on the tree.

  • Name and status change

    From January 2016 the  Prostate Cancer Support Federation is changing its charitable status and will be known as the National Federation of Prostate Cancer Support Groups. It will retain the Tackle name as its public face.

  • Bristol ‘breakthrough’

    Bristol University scientists have made a breakthrough in treating prostate cancer. Injections have been tested on mice and could be tested on patients before long. Sebastian Oltean from the university gave us a talk on this in January

  • ‘Grenades’ tackle tumours

    Scientists have designed microscopic “grenades” that can explode their cancer-killing payload in tumours. The team presented its findings at the National Cancer Research Institute conference in November. The plan is to use liposomes – tiny bubbles of fat which carry materials round the body – to release toxic drugs when their temperature is raised.

  • New info for Black men

    One in 4 Black men will get prostate cancer at some point. That’s double the overall one in 8 risk faced by all UK men. Prostate Cancer UK’s updated leaflet has all the information you need to know if you’re at risk: See

  • New cancer test on way

    A ÂŁ10 urine test for prostate cancer which not only picks up the disease but also reveals the size of tumours so that doctors know whether to operate could be available within 18 months, the Daily Telegraph reported in September. See

  • Xofigo® drug withdrawn

    As the Cancer Drugs Fund (CDF), set up to pay for new, expensive cancer drugs, is no longer affordable, NHS England has decided to stop funding radium-223 (Xofigo®) for new advanced prostate cancer patients. Men on the drug will not be affected. Abiraterone and enzalutamide will remain on the CDF. See report

  • Drug might stop cancer spread

    A molecule has been identified that could be central to the mechanism of the spread of prostate cancer. The study, published in the journal Cancer Cell, was completed by researchers from the Thomas Jefferson University in Philadelphia. The results have led to the development of a drug that could prevent metastasis in prostate cancer – and possibly other cancers. The drug that inhibits the molecule DNA-PKcs is being tested. See

  • Five types of prostate cancer found

    New research published in July by researchers revealed that prostate cancer can be divided into five distinct groups, each with a unique molecular signature that appears to predict how well a patient will do after surgery. It was stressed there were still many questions to be ironed out. See

  • Space tool may detect prostate cancer

    An instrument of a type found on board Philae, the comet 67P lander, is being used in the search for a non-invasive detection of prostate cancer. The instrument is a gas chromatograph-mass spectrometer which sniffs and analyses the main chemical compounds that make up the comet.  The tool, developed by Open University scientists and Rutherford Appleton Laboratory, is being trialled in such projects as testing submarines’ air quality and in the fight against bed bugs  – Open Minds, the magazine for OU alumni


A friendly and supportive network that aims to:

We have found that knowledge is of great benefit to the patient. It enables him to play an active part in the decision-making process, for example in selecting the best treatment.

We offer a friendly welcome – come and join us

Are you just diagnosed, or do you suspect that you may have prostate cancer? Then for friendly peer support and an introduction to Prospect call or text our helpline on

07585 963535

This site has been compiled by prostate cancer survivors. We do not claim to have specialist knowledge other than that gained by prostate cancer patients during their treatment.

Regional co-ordinator needed

Tackle need a Regional Co-ordinator for Western Counties. The holder acts as a focal point for communications on region-specific topics between the chairman, Roger Wotton, and member groups in the area. See. In addition, he or she will participate in occasional meetings or teleconferences of regional co-ordinators. If any of Prospect’s members would like to volunteer for this rewarding role, they can email roger.wotton@tackleprostate.org All expenses are reimbursed. Tackle’s plans for regional meetings in 2016 will explore specific issues of regional/local interest and Prospect members’ views are welcome on what the preferred theme might be for the workshops.

New research strategy launched

Prostate Cancer UK has launched an ambitious 10-year strategy setting out how it will invest in the most innovative research to create a step change in our knowledge of prostate cancer. See

Tumours zapped with ‘lightning’

An emerging treatment for prostate cancer that involves zapping a tumour with more electricity than a bolt of lightning had been reported in Australia. Pulses of electricity pass between needles inserted in a lesion, which disappears. The technology is known as the “nanoknife”. It targets only the site of the cancer, destroying that without the structures surrounding it. Urologists in three countries are trialling the technology on patients who have a single site of localised prostate cancer that needs more treatment than active surveillance. About 15 to 20 per cent of prostate cancer patients are suitable for the treatment, it’s claimed. See

Swedish test shows promise

Swedish researchers found that a test which involved genetic and protein biomarkers (the S3M) was much better than PSA alone at detecting potentially dangerous prostate cancers. The Swedish results give compelling evidence  the S3M risk assessment model can dramatically cut the number of men undergoing unnecessary biopsies, without compromising their safety. But Prostate Cancer UK say it’s going to be important to validate this study in a more diverse population before they can accept that it will work elsewhere. See

We give illustrated talks

Mike Broxton gives prostate cancer awareness talks to interested groups, including those with learning disabilities. To arrange a talk, contact prospect.bristol@gmail.com or 07585 963535.

New secretary volunteers

Chris Millett  volunteered to be our secretary after an appeal at the AGM. A successful year was reported and the committee was re-elected. Since then, Fiona Perry has joined the committee.

Treatment difficulties

The government are reviewing how to speed up access to treatments on the NHS and they wanted patients’ input. Prostate Cancer UK thought this was a good opportunity to tell them some of the difficulties men have had in accessing treatments. If your clinician judged your circumstances to be exceptional, they might have lodged an Individual Funding Request to see if you could receive a treatment not available on the NHS. If you knew that this was the case for you and the application was unsuccessful, Prostate Cancer UK wanted to share your experience with government. That exercise has ended, but Prostate Cancer UK still want to hear from any unsuccessful applicants.

  • Know your risk

    Prostate Cancer UK has a new infographic and booklets.

    Treatment help

    www.myprostate.eu is now also available in English and prostate cancer patients can exchange information and help each other with treatment decisions.

  • Buddies support

    A NEW emotional support service is being offered to people affected by cancer, called Macmillan Skype Buddy. To use it, you need Skype and an email account. The charity is also looking for volunteers to train as buddies.

  • Macmillan Bristol Buddies

    A new service to support adult cancer patients. It offers emotional and practical support in people’s homes for up to 12 weeks across Bristol. Ring 07543 248714 or email